GlassScriptPhysician profile
Madelyn M Nickerson
NPI 1609327816
$1,443.52
in general payments reported to CMS, 2019-2025
17 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $310 · 2023: $56.90 · 2024: $88.47 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.62 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $308.38 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $130.79 | 2021-2025 | Airsupra |
| Exact Sciences Corporation | $104.49 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.51 | 2021-2022 | |
| Pfizer INC. | $81.39 | 2025 | |
| Glaxosmithkline, LLC. | $75.28 | 2022 | |
| Lilly USA, LLC | $52.10 | 2021-2025 | Zepbound, Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $43.53 | 2022 | |
| Merck Sharp & Dohme LLC | $41.95 | 2021-2025 | Capvaxive, Gardasil 9 |
| Amarin Pharma, INC. | $39.77 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.53 | 2021 | |
| Phathom Pharmaceuticals, INC. | $21.36 | 2025 | Voquezna |
| Amgen INC. | $18.44 | 2025 | Repatha |
| Ipsen Biopharmaceuticals, INC | $16.27 | 2025 | Iqirvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $14.72 | 2021 | |
| Abbott Laboratories | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madelyn Nickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.